Through purpose-driven science, empowering medicines, and transformative advocacy we seek to improve the lives of millions.
Our areas of focus
Uterine Fibroids
An estimated 5 million people in the U.S. suffer from symptoms of uterine fibroids.
Prostate Cancer
Approximately 3 million people alive today in the U.S. have been diagnosed with prostate cancer.
PURPOSE-DRIVEN SCIENCE
Myovant is developing innovative medicines that hold promise to improve people’s lives.
On Twitter
News
View more newsSTATEMENT
30 Jun 2022
Myovant Statement: U.S. Supreme Court Ruling in Dobbs v. Jackson Women’s Health Organization